Teladoc Health, Inc. (TDOC) Earning

$9.51

north_east $0.25 (2.7%)
Day's range
$8.96
Day's range
$9.57

Teladoc Health, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 8 -$0.48 -$0.44 -$0.46
Q2 2024 8 -$0.36 -$0.33 -$0.34
Q3 2024 2 -$0.29 -$0.27 -$0.28
Q4 2024 6 -$0.32 -$0.03 -$0.23
Q1 2025 5 -$0.38 -$0.19 -$0.31
Q2 2025 4 -$0.24 -$0.22 -$0.23
Q3 2025 4 -$0.22 -$0.20 -$0.21
Q4 2025 4 -$0.15 -$0.14 -$0.14
Q1 2026 3 -$0.36 -$0.33 -$0.35
Q2 2026 3 -$0.28 -$0.25 -$0.26
Q3 2026 3 -$0.26 -$0.23 -$0.24
Q4 2026 3 -$0.21 -$0.19 -$0.20
Q1 2027 3 -$0.28 -$0.26 -$0.27
Q2 2027 3 -$0.21 -$0.19 -$0.20
Q3 2027 3 -$0.11 -$0.10 -$0.10
Q4 2027 3 $0.17 $0.19 $0.18

Teladoc Health, Inc. Earnings Date And Information

Teladoc Health, Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.1. The company had revenue of 640.51 M for the quarter and had revenue of 2.60 B for the year. Teladoc Health, Inc. has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -1.65. Teladoc Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.

Teladoc Health, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2024 Q3 2024 -$0.20 $631.18 M $640.51 M
08/01/2024 Q2 2024 -$4.92 $649.16 M $642.44 M
04/26/2024 Q1 2024 -$0.49 $646.13 M
02/23/2024 Q4 2023 -$0.17 $660.53 M
10/27/2023 Q3 2023 -$0.35 $663.54 M $660.24 M
07/28/2023 Q2 2023 -$0.40 $649.18 M $652.41 M
05/02/2023 Q1 2023 -$0.42 $629.24 M
03/01/2023 Q4 2022 -$23.49 $637.71 M
11/02/2022 Q3 2022 -$0.45 $608.89 M $611.40 M
08/03/2022 Q2 2022 -$19.22 $586.74 M $592.38 M
05/02/2022 Q1 2022 -$41.58 $565.35 M
02/28/2022 Q4 2021 -$0.07 $554.24 M
11/01/2021 Q3 2021 -$0.53 $516.63 M $521.66 M
08/02/2021 Q2 2021 -$0.86 $500.60 M $503.14 M
05/03/2021 Q1 2021 -$1.31 $453.68 M
03/01/2021 Q4 2020 -$3.07 $383.32 M
11/06/2020 Q3 2020 -$0.43 $282.18 M $288.81 M
07/29/2020 Q2 2020 -$0.23 -$0.34 -0.11 $220.67 M $241.03 M
04/29/2020 Q1 2020 -$0.35 -$0.40 -0.05 $180.80 M
02/26/2020 Q4 2019 -$0.33 -$0.26 0.07 $156.49 M
 

Teladoc Health, Inc. Earnings: FAQ's

When is Teladoc Health, Inc.'s earnings date?

Teladoc Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.

Did Teladoc Health, Inc. beat their earnings estimates last quarter?

In the previous quarter, Teladoc Health, Inc. (:TDOC) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.1.

How can I listen to Teladoc Health, Inc.'s earnings conference call?

The conference call for Teladoc Health, Inc.'s latest earnings report can be listened to online.

How can I read Teladoc Health, Inc.'s conference call transcript?

The conference call transcript for Teladoc Health, Inc.'s latest earnings report can be read online.

How much revenue does Teladoc Health, Inc. generate each year?

Teladoc Health, Inc. (:TDOC) has a recorded annual revenue of $2.60 B.

How much profit does Teladoc Health, Inc. generate each year?

Teladoc Health, Inc. (:TDOC) has a recorded net income of $2.60 B. Teladoc Health, Inc. has generated $-1.36 earnings per share over the last four quarters.

What is Teladoc Health, Inc.'s price-to-earnings ratio?

Teladoc Health, Inc. (:TDOC) has a price-to-earnings ratio of -1.65 and price/earnings-to-growth ratio is -0.65.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED